# Biomarker Identification of Radionuclide Therapy-induced Radiation Responses

> **NCT05513469** · NA · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** Lutathera

## Key facts

- **NCT ID:** NCT05513469
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05513469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05513469, "Biomarker Identification of Radionuclide Therapy-induced Radiation Responses". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05513469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*